Cas:153597-59-2 ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate manufacturer & supplier

Chemical Name:ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate

CAS.NO:153597-59-2

Synonyms:ethyl 5H,6H,7H-pyrazolo[3,2-b][1,3]oxazine-2-carboxylate;5H-Pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid,6,7-dihydro-,ethylester;ethyl6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate

Molecular Formula:C₉H₁₂N₂O₃

Molecular Weight:196.20300

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:53.35000

Exact Mass:196.08500

LogP:0.84230

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethyl 5H,6H,7H-pyrazolo[3,2-b][1,3]oxazine-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 5H,6H,7H-pyrazolo[3,2-b][1,3]oxazine-2-carboxylate Use and application,5H-Pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid,6,7-dihydro-,ethylester technical grade,usp/ep/jp grade.

Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate manufacturer Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate supplier This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body. ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate vendor With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylate factory It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.